These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Bortezomib use in chronic antibody-mediated allograft dysfunction: a report of three cases. Cooper JE; Wiseman AC; Chan L Clin Transpl; 2009; ():455-9. PubMed ID: 20524314 [No Abstract] [Full Text] [Related]
5. Bortezomib for refractory antibody-mediated cardiac allograft rejection. Eckman PM; Thorsgard M; Maurer D; Kim Y; Alloway RR; Woodle ES Clin Transpl; 2009; ():475-8. PubMed ID: 20524318 [TBL] [Abstract][Full Text] [Related]
6. The role of proteasome inhibition with bortezomib in the treatment of antibody-mediated rejection after kidney-only or kidney-combined organ transplantation. Flechner SM; Fatica R; Askar M; Stephany BR; Poggio E; Koo A; Banning S; Chiesa-Vottero A; Srinivas T Transplantation; 2010 Dec; 90(12):1486-92. PubMed ID: 21042239 [TBL] [Abstract][Full Text] [Related]
7. Proteasome inhibitor treatment of antibody-mediated allograft rejection. Woodle ES; Alloway RR; Girnita A Curr Opin Organ Transplant; 2011 Aug; 16(4):434-8. PubMed ID: 21753709 [TBL] [Abstract][Full Text] [Related]
8. Rescue therapy for early antibody mediated rejection with a proteasome inhibitor: a case report. Manitpisitkul W; Wilson N; Cooper M; Gurk-Turner C; Hurley H; Rasetto F; KuKuruga D; Barth RN; Philosophe B Clin Transpl; 2009; ():461-3. PubMed ID: 20524315 [No Abstract] [Full Text] [Related]
13. Use of bortezomib for prevention and treatment of rejection in sensitized patients. Hartono C; Lubetzky M; Aull MJ; Saal S; Figueiro J; Kapur S; Dadhania D Clin Transpl; 2009; ():499-503. PubMed ID: 20524323 [TBL] [Abstract][Full Text] [Related]
14. Bortezomib alone fails to decrease donor specific anti-HLA antibodies: 4 case reports. Sberro-Soussan R; Zuber J; Suberbielle-Boissel C; Legendre C Clin Transpl; 2009; ():433-8. PubMed ID: 20524311 [TBL] [Abstract][Full Text] [Related]
15. Case presentations on two patients who received bortezomib for antibody mediated rejection at BIDMC. Pavlakis M Clin Transpl; 2009; ():343-5. PubMed ID: 20524296 [TBL] [Abstract][Full Text] [Related]
16. Successful treatment with bortezomib of a refractory humoral rejection of the intestine after multivisceral transplantation. Island ER; Gonzalez-Pinto IM; Tsai HL; Ruiz P; Tryphonopoulos P; Gonzalez ML; Solano JP; Rossique M; Selvaggi G; Tekin A; Smith LJ; Tzakis AG Clin Transpl; 2009; ():465-9. PubMed ID: 20524316 [TBL] [Abstract][Full Text] [Related]